| |
| |
|
| Insider
Information: |
Socks David A |
| Relationship: |
Officer |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
105,245 |
|
|
Indirect Shares
|
1,980,811 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$10,466,839 |
|
|
| Total
Shares |
2,086,056 |
|
|
| Total
Value |
$10,466,839 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cadence Pharmaceuticals Inc |
CADX |
SVP |
2010-06-14 |
96,245 |
|
0 |
Premium* |
|
|
Phathom Pharmaceuticals, Inc. |
PHAT |
Director |
2023-05-25 |
9,000 |
2023-05-25 |
1,211,756 |
Premium* |
|
|
Hillevax, Inc. |
HLVX |
Officer |
|
0 |
2022-04-28 |
769,055 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2023-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
9,000 |
0 |
- |
|
| HLVX |
Hillevax, Inc. |
CFO & Chief Business OfficerOf |
• – – |
2022-04-28 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
769,055 |
|
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2021-10-08 |
4 |
AS |
$32.05 |
$81,052 |
I/I |
(2,529) |
1,211,346 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2021-10-07 |
4 |
AS |
$32.66 |
$505,343 |
I/I |
(15,471) |
1,213,875 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2021-09-22 |
4 |
AS |
$32.06 |
$131,446 |
I/I |
(4,100) |
1,229,346 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2021-09-21 |
4 |
AS |
$32.79 |
$455,905 |
I/I |
(13,900) |
1,233,446 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2021-08-16 |
4 |
AS |
$30.47 |
$562,538 |
I/I |
(18,000) |
1,247,346 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2021-06-29 |
4 |
AS |
$34.00 |
$474,657 |
I/I |
(13,960) |
1,260,945 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2021-06-28 |
4 |
AS |
$34.07 |
$887,284 |
I/I |
(26,040) |
1,274,905 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2021-05-20 |
4 |
AS |
$33.76 |
$120,687 |
I/I |
(3,482) |
1,300,945 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2021-05-19 |
4 |
AS |
$31.96 |
$1,184,819 |
I/I |
(36,518) |
1,304,427 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2021-04-06 |
4 |
AS |
$34.96 |
$664,684 |
I/I |
(17,882) |
1,340,945 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2021-04-05 |
4 |
AS |
$35.69 |
$797,405 |
I/I |
(22,118) |
1,358,827 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2021-03-12 |
4 |
AS |
$46.67 |
$23,335 |
I/I |
(500) |
1,380,945 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2021-03-11 |
4 |
AS |
$47.18 |
$2,002,098 |
I/I |
(42,429) |
1,381,445 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2021-03-10 |
4 |
AS |
$48.32 |
$591,657 |
I/I |
(12,071) |
1,423,874 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2021-02-23 |
4 |
AS |
$42.50 |
$217,991 |
I/I |
(4,984) |
1,435,945 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2021-02-22 |
4 |
AS |
$45.27 |
$919,587 |
I/I |
(20,140) |
1,440,929 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2021-02-19 |
4 |
AS |
$46.02 |
$2,117,034 |
I/I |
(44,876) |
1,461,069 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2021-01-12 |
4 |
AS |
$35.74 |
$979,795 |
I/I |
(27,165) |
1,532,945 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2021-01-11 |
4 |
AS |
$34.92 |
$448,243 |
I/I |
(12,835) |
1,560,110 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2020-12-17 |
4 |
AS |
$40.49 |
$1,964,376 |
I/I |
(48,212) |
1,572,945 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2020-12-16 |
4 |
AS |
$46.22 |
$1,494,519 |
I/I |
(31,446) |
1,621,157 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2020-11-11 |
4 |
AS |
$38.17 |
$268,021 |
I/I |
(6,877) |
1,652,603 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2020-11-10 |
4 |
AS |
$41.29 |
$528,672 |
I/I |
(12,681) |
1,659,480 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
